Страна: Австралія
мова: англійська
Джерело: Department of Health (Therapeutic Goods Administration)
fexofenadine hydrochloride, Quantity: 60 mg
Sanofi-Aventis Healthcare Pty Ltd T/A Sanofi Consumer Healthcare
Fexofenadine hydrochloride
Tablet, film coated
Excipient Ingredients: microcrystalline cellulose; magnesium stearate; colloidal anhydrous silica; croscarmellose sodium; titanium dioxide; povidone; pregelatinised maize starch; hypromellose; macrogol 400; iron oxide red; iron oxide yellow
Oral
20 Not to be supplied before the effective date of the amendment to the Poisons Schedule, 10
Not Scheduled after consideration by Committee
Relief of symptoms associated with seasonal allergic rhinitis in adults and children aged 12 years and older.
Visual Identification: Peach, oval, double convex, tablets, debossed with ?06? on one side and a scripted ?e? on the other.; Container Type: Blister Pack; Container Material: PVC/PE/PVDC/Al; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius
Licence status A
2009-10-13